Once-weekly efsitora noninferior to daily insulin in T2D
Three trials from the QWINT global phase 3 clinical trial programme has found that the once-weekly basal insulin analog efsitora alfa lowers HbA1c as effectively
Three trials from the QWINT global phase 3 clinical trial programme has found that the once-weekly basal insulin analog efsitora alfa lowers HbA1c as effectively
Recent research has found that, over 10 years, Roux-en-Y gastric bypass (RYGB) leads to greater excess body mass index (BMI) loss than sleeve gastrectomy in
A case study has shown how inequality in access to diabetes technologies has been overcome though a Diabetes Intervention Worker Pilot by Somerset NHS Foundation
Insulet has announced a new collaboration with Marvel Entertainment to launch a comic book featuring a hero who lives with Type 1 diabetes. The comic
Roche has announced that it plans to invest up to $550m to expand its continuous glucose monitoring (CGM) site in the US. The company plans
Sequel Med Tech has announced that it has agreed to integrate its twiist automated insulin delivery system with Abbott‘s glucose-ketone sensor, which is currently under
Obesity has historically been regarded as a moral failing, and people with obesity describe being seen as deficient, lazy, and/or undeserving of respect, lacking willpower
A new device based on research from Indiana University could one day supplement current methods to provide better protection against more serious swings in blood
Insulet Corporation has announced that its Omnipod 5 is now compatible with the Dexcom G7 Continuous Glucose Monitor (CGM) in the UK and Netherlands. The
My Way Digital health have launched free Open Online Courses (OOCs) which are QISMET approved and open to anyone that wishes to take a digital